Socioeconomic disparities in survival after high-risk neuroblastoma treatment with modern therapy.

ABSTRACT:

Background

Modern therapeutic advances in high-risk neuroblastoma have improved overall survival (OS), but it is unclear whether these survival gains have been equitable. This study examined the relationship between socioeconomic status (SES) and overall survival (OS) in children with high-risk neuroblastoma and whether SES-associated disparities have changed over time.

Procedure

In this population-based cohort study, children <18 years diagnosed with high-risk neuroblastoma (diagnosis at age ≥12 months with metastatic disease) from 1991 to 2015 were identified through the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Associations of county-level SES variables and OS were tested with univariate Cox proportional hazards regression. For a su

SUBMITTER: Zheng DJ 

PROVIDER: S-EPMC8384664 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature